Details for Patent: 7,250,419
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
Summary for Patent: 7,250,419
Title: | Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
Abstract: | The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation. |
Inventor(s): | Hardern; David (Sutton Bonington, GB), Ingall; Anthony (Loughborough, GB), Springthorpe; Brian (Loughborough, GB), Willis; Paul (West Bridgford, GB), Guile; Simon (Loughborough, GB) |
Assignee: | AstraZeneca AB (Sodertalje, SE) |
Application Number: | 11/230,493 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,250,419 |
Patent Claim Types: see list of patent claims | Compound; Composition; Use; |
Drugs Protected by US Patent 7,250,419
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,250,419
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 023920 | ⤷ Sign Up | |||
Argentina | 058967 | ⤷ Sign Up | |||
Argentina | 072756 | ⤷ Sign Up | |||
Austria | 261970 | ⤷ Sign Up | |||
Austria | 418547 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |